As healthcare costs and drug prices continue to increase in countries across the world, governments and policy makers are beginning to actively promote both the development and the use of generic drugs. Generics are cost-effective [...]
It is no secret that pharmaceutical companies are being blamed left, right and center for rising healthcare costs. A series of high-profile cases, including Turing Pharmaceuticals’ 5,000% price increase of its Toxoplasmosis drug, Daraprim, and [...]
When Donald Trump took office earlier this year, he promised to bring some big changes to the US healthcare system. Along with slashing drug prices, and making health insurance more affordable and accessible for all [...]
When Sarepta Therapeutics’ Duchene muscular dystrophy (DMD) drug, Exondys 51, got the green light from the US FDA last September, it became most controversial drug approvals of 2016. FDA Commissioner at the time, Robert Califf, [...]